CXCL8 and neoplasm: Both trials further suggest that greater CXCL8 expression in tumor is associated with higher plasma CXCL8 level, an immunosuppressive myeloid-enriched TME, and T cell suppression (Schalper et al., 2020; Yuen et al., 2020).